Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$392,409,044
+$231,268,086 QoQ
Shares Held
1,545,100
+134.4% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
1.72%
of 13F equity value
Holder Rank
#122
of 4,664 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AGF MANAGEMENT LTD holds $1,321,975,737 across 10 Drug Manufacturers - General names. JNJ ranks #2 (29.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
556,470 | $667,446,866 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,545,100 | $392,409,044 | |
| 3 | ABBV |
AbbVie Inc.
|
652,937 | $164,305,065 | |
| 4 | NVS |
Novartis AG
|
360,354 | $56,474,678 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
334,104 | $19,251,072 | |
| 6 | PFE |
Pfizer Inc
|
434,814 | $10,470,321 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
43,538 | $5,500,590 | |
| 8 | AMGN |
Amgen Inc
|
9,492 | $3,437,243 |
All Filings in JNJ
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $392,409,044 | 1,545,100 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $161,140,958 | 659,225 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $118,531,646 | 572,755 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $109,165,095 | 588,745 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $91,033,194 | 595,962 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $95,512,230 | 575,930 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $82,993,945 | 573,876 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $97,194,024 | 599,741 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $87,279,881 | 597,153 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $97,455,479 | 616,066 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $101,313,129 | 646,377 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $67,226,683 | 431,632 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $107,787,947 | 651,208 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $140,981,955 | 909,561 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $124,619,154 | 705,458 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||